1. Agomelatine associated with hypotension?

   News item 11 October 2014 Pages: 1 - 1

2. Dronedarone associated with polyneuropathy?

   News item 11 October 2014 Pages: 2 - 2

3. EMA confirms positive benefit−risk for agomelatine

   News item 11 October 2014 Pages: 3 - 3

4. FDA warns not to use Bo Ying Compound

   News item 11 October 2014 Pages: 4 - 4

5. Finasteride may increase risk of seizures

   News item 11 October 2014 Pages: 5 - 5

6. Nitrofurantoin contraindicated in renal impairment

   News item 11 October 2014 Pages: 6 - 6

7. Omalizumab labelling changes: risk of heart disorders and TIA

   News item 11 October 2014 Pages: 7 - 7

8. Patients to discuss benefit−risk with CHMP

   News item 11 October 2014 Pages: 8 - 8

9. New Yellow Card guidelines for ADRs in children

   News item 11 October 2014 Pages: 9 - 9

10. Adverse effects more likely with intermediate-acting insulins

    Clinical study 11 October 2014 Pages: 10 - 10

11. Antibiotics in infancy: risk of childhood obesity

    Clinical study 11 October 2014 Pages: 11 - 11

12. Less toxicity with targeted therapies spells lower costs

    News item 11 October 2014 Pages: 12 - 12

13. NSAIDs increase the risk of VTE

    Clinical study 11 October 2014 Pages: 13 - 13

14. Substandard drugs marketed in Africa

    Clinical study 11 October 2014 Pages: 14 - 14

15. γ-globulin

    Case report 11 October 2014 Pages: 15 - 15

16. Aciclovir

    Case report 11 October 2014 Pages: 16 - 16

17. Aciclovir

    Case report 11 October 2014 Pages: 17 - 17

18. Albendazole/cetirizine

    Case report 11 October 2014 Pages: 18 - 18

19. Alendronic acid/denosumab

    Case report 11 October 2014 Pages: 19 - 19

20. Alendronic acid/zoledronic acid

    Case report 11 October 2014 Pages: 20 - 20

21. Alfacalcidol/calcium carbonate

    Case report 11 October 2014 Pages: 21 - 21

22. Aliskiren

    Case report 11 October 2014 Pages: 22 - 22

23. Amiodarone/atazanavir interaction

    Case report 11 October 2014 Pages: 23 - 23

24. Amitriptyline/paracetamol/tramadol

    Case report 11 October 2014 Pages: 24 - 24

25. Amoxicillin/clarithromycin/omeprazole

    Case report 11 October 2014 Pages: 25 - 25

26. Amoxicillin/clavulanic acid

    Case report 11 October 2014 Pages: 26 - 26

27. Amphotericin B

    Case report 11 October 2014 Pages: 27 - 27

28. Antibacterials/antipyretics/gallium citrate

    Case report 11 October 2014 Pages: 28 - 28

29. Antibacterials/bismuth pectin/lansoprazole

    Case report 11 October 2014 Pages: 29 - 29

30. Antineoplastics

    Case report 11 October 2014 Pages: 30 - 30

31. Antineoplastics

    Case report 11 October 2014 Pages: 31 - 31

32. Antineoplastics/antivirals

    Case report 11 October 2014 Pages: 32 - 32

33. Antipsychotics

    Case report 11 October 2014 Pages: 33 - 33

34. Antiretrovirals/cotrimoxazole

    Case report 11 October 2014 Pages: 34 - 34

35. Antiretrovirals/tacrolimus

    Case report 11 October 2014 Pages: 35 - 35

36. Antitubercular drugs

    Case report 11 October 2014 Pages: 36 - 36

37. Antituberculars

    Case report 11 October 2014 Pages: 37 - 37

38. Aripiprazole

    Case report 11 October 2014 Pages: 38 - 38

39. Asparaginase

    Case report 11 October 2014 Pages: 39 - 39

40. Aspirin/clopidogrel

    Case report 11 October 2014 Pages: 40 - 40

41. Atomoxetine/haloperidol/niaprazine/sodium valproate

    Case report 11 October 2014 Pages: 41 - 41

42. Atracurium besilate

    Case report 11 October 2014 Pages: 42 - 42

43. Azathioprine

    Case report 11 October 2014 Pages: 43 - 43

44. Azathioprine

    Case report 11 October 2014 Pages: 44 - 44

45. Azathioprine/methotrexate

    Case report 11 October 2014 Pages: 45 - 45

46. BCG vaccine

    Case report 11 October 2014 Pages: 46 - 46

47. Benzathine benzylpenicillin

    Case report 11 October 2014 Pages: 47 - 47

48. Bevacizumab/cisplatin/pemetrexed

    Case report 11 October 2014 Pages: 48 - 48

49. Bleomycin

    Case report 11 October 2014 Pages: 49 - 49

50. Boceprevir/peginterferon/ribavirin

    Case report 11 October 2014 Pages: 50 - 50